ストックスクリーナーアプリを入手
12.23
4.53%
-0.58
プレマーケット:
12.15
-0.08
-0.65%
Novocure Ltd (NVCR) 最新ニュース
Can momentum traders help lift NovoCure LimitedJuly 2025 PostEarnings & Free Weekly Chart Analysis and Trade Guides - newser.com
Can NovoCure Limited stock deliver sustainable ROETrade Volume Summary & Fast Exit Strategy with Risk Control - newser.com
NovoCure (NVCR) Is Down 5.7% After Q3 Revenue Growth and Expanded International Coverage — Has the Growth Story Changed? - simplywall.st
Measuring NovoCure Limited’s beta against major indicesPrice Action & Reliable Volume Spike Trade Alerts - newser.com
HC Wainwright Increases Earnings Estimates for NovoCure - MarketBeat
Chart overlay techniques for tracking NovoCure LimitedQuarterly Trade Summary & Free Safe Entry Trade Signal Reports - newser.com
How to recover losses in NovoCure Limited stockQuarterly Market Summary & Stepwise Entry/Exit Trade Alerts - newser.com
How NovoCure Limited (038) stock responds to job market shiftsJuly 2025 Breakouts & Weekly Setup with High ROI Potential - newser.com
Is NovoCure Limited stock attractive for hedge fundsGDP Growth & Pattern Based Trade Signal System - newser.com
Is NovoCure Limited stock oversold or undervaluedGap Up & Weekly Momentum Stock Picks - newser.com
NovoCure Limited (NASDAQ:NVCR) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
NovoCure Limited (NASDAQ:NVCR) Q3 2025 Earnings Call Transcript - Insider Monkey
How interest rate cuts could boost NovoCure Limited stockJuly 2025 Opening Moves & Verified Chart Pattern Signals - newser.com
What does recent volatility data suggest for NovoCure LimitedJuly 2025 Reactions & Consistent Profit Trade Alerts - newser.com
NovoCure’s Mixed Q3: Growth Amid Challenges - TipRanks
NovoCure (NVCR): Losses Worsen, Testing Bullish Narrative on Valuation and Growth Potential - simplywall.st
NovoCure (NASDAQ:NVCR) Announces Quarterly Earnings Results - MarketBeat
NovoCure (NASDAQ:NVCR) Price Target Raised to $42.00 - MarketBeat
NovoCure: Q3 Earnings Snapshot - Stamford Advocate
Novocure Ltd earnings beat by $0.09, revenue topped estimates - Investing.com UK
Emerald Mutual Fund Advisers Trust Reduces Position in NovoCure Limited $NVCR - MarketBeat
NovoCure Expands Global Reach Within Nasdaq Today Trends - Kalkine Media
Novocure Ltd. Reports Q3 2025 Financial Results - TipRanks
Order flow analysis tools used on NovoCure Limited2025 Top Decliners & AI Driven Price Predictions - newser.com
Decoding NovoCure Ltd (NVCR): A Strategic SWOT Insight - GuruFocus
HC Wainwright & Co. Raises PT for NVCR, Maintains Buy Rating | N - GuruFocus
Assessing NovoCure (NVCR) Valuation as Investors Revisit Recovery Potential - simplywall.st
NovoCure Ltd (NVCR) Q3 2025 Earnings Call Highlights: Revenue Growth Amidst Challenges - Yahoo Finance
Novocure’s Revenue Beats Forecasts As Cancer Pipeline Expands - Finimize
Compared to Estimates, NovoCure (NVCR) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
Novocure (NVCR) Exceeds Q3 Revenue Expectations with Strong Grow - GuruFocus
Emerald Advisers LLC Lowers Stock Position in NovoCure Limited $NVCR - MarketBeat
NovoCure Ltd (NVCR) Q3 Earnings: EPS Loss of $0.33 Beats Estimat - GuruFocus
Novocure (NASDAQ: NVCR) posts $167.2M revenue for the quarter; 4,416 patients on therapy - Stock Titan
Can NovoCure Limited hit a new high this monthJuly 2025 Chart Watch & Safe Entry Point Identification - newser.com
NovoCure (NASDAQ:NVCR) Given New $23.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Real time breakdown of NovoCure Limited stock performanceWeekly Risk Summary & Weekly Setup with High ROI Potential - newser.com
Is NovoCure Limited stock a safe investment in uncertain marketsJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
Why NovoCure Limited stock remains undervaluedQuarterly Earnings Report & High Accuracy Trade Alerts - newser.com
Will NovoCure Limited stock attract more institutional investorsQuarterly Risk Review & Accurate Entry and Exit Point Alerts - newser.com
Detecting support and resistance levels for NovoCure LimitedJuly 2025 Patterns & Risk Controlled Swing Alerts - newser.com
Is NovoCure Limited (038) stock testing key supportJuly 2025 Sector Moves & Real-Time Market Sentiment Alerts - newser.com
NovoCure’s Phase 3 Glioblastoma Study: A Potential Game-Changer in Cancer Treatment - TipRanks
Will NovoCure Limited (038) stock profit from automation waveMarket Movement Recap & Expert Verified Stock Movement Alerts - fcp.pa.gov.br
JP Morgan Maintains NovoCure (NVCR) Neutral Recommendation - Nasdaq
NovoCure’s LUNAR-2 Study: A New Horizon in Lung Cancer Treatment - TipRanks
Will NovoCure Limited stock outperform growth indexes2025 Top Decliners & Low Risk Entry Point Guides - fcp.pa.gov.br
NovoCure’s TIGER Meso Study: A Promising Update for Pleural Mesothelioma Treatment - TipRanks
NovoCure’s LUNAR-4 Study: A New Horizon in Lung Cancer Treatment - TipRanks
How strong is NovoCure Limited stock revenue growthTrade Exit Summary & Entry Point Strategy Guides - fcp.pa.gov.br
NovoCure’s TIGER France Study: A Potential Game-Changer for Glioblastoma Treatment - TipRanks
JP Morgan Maintains Neutral Rating on NVCR, Lowers Price Target - GuruFocus
1.84%
0.40%
大文字化:
|
ボリューム (24 時間):